Delhi | 25°C (windy)

Unlocking the Epigenetic Code: Thelma Escobar Reveals New Insights into Stem Cells and Cancer

  • Nishadil
  • October 16, 2025
  • 0 Comments
  • 2 minutes read
  • 4 Views
Unlocking the Epigenetic Code: Thelma Escobar Reveals New Insights into Stem Cells and Cancer

In a compelling presentation, Thelma Escobar, a Ph.D. candidate in the Cellular and Molecular Medicine Program, illuminated the intricate world of epigenetics and its profound implications for hematopoietic stem cells (HSCs) and cancer. Her talk, part of the distinguished Cancer Biology Training Program, offered a deep dive into how subtle modifications to our DNA can dramatically influence cell behavior and disease progression.

Escobar began by demystifying epigenetics, explaining how these crucial mechanisms alter gene expression without ever changing the underlying DNA sequence.

Instead, through processes like DNA methylation and histone modifications, our cells can 'switch' genes on or off, dictating the fate of vital cells like HSCs. These remarkable stem cells are the architects of our blood system, responsible for continuously generating all types of blood cells. Understanding their regulation is key to unraveling both normal physiological processes and the genesis of diseases.

A significant focus of Escobar’s research is Acute Myeloid Leukemia (AML), a devastating cancer of the blood and bone marrow.

She highlighted the critical role of mutations in DNMT3A, a DNA methyltransferase enzyme, which are frequently found in AML patients. When DNMT3A is mutated, the finely tuned epigenetic landscape of HSCs is disrupted, leading to aberrant gene expression patterns that drive leukemic transformation. This enzyme is normally responsible for adding methyl groups to DNA, a process vital for gene silencing and maintaining cellular identity.

Escobar shared her groundbreaking findings on how these DNMT3A mutations precisely impact HSCs.

Her work delves into the specific effects on transcription factors—proteins that control gene activity—and chromatin accessibility, which determines how tightly DNA is packed and thus how accessible genes are for expression. By meticulously investigating these changes, she has begun to unravel the complex molecular cascade that transforms healthy HSCs into cancerous ones.

Her presentation detailed how DNMT3A mutations lead to altered expression of lineage-specific genes, skewing the differentiation pathways of HSCs.

This misguidance prevents them from developing into functional blood cells and instead promotes the proliferation of immature, cancerous cells. The implications of her research are vast, opening new avenues for understanding AML pathogenesis and potentially paving the way for targeted therapeutic interventions that can correct these epigenetic errors.

Escobar's work stands as a testament to the power of basic science in confronting complex diseases like cancer.

.

Disclaimer: This article was generated in part using artificial intelligence and may contain errors or omissions. The content is provided for informational purposes only and does not constitute professional advice. We makes no representations or warranties regarding its accuracy, completeness, or reliability. Readers are advised to verify the information independently before relying on